Role of PET Role of PET-CT in Pulmonary Malignancy

More documents

Recommendations

Info

N stagingCT PETMeta-analysisanalysis sens / spec sens / spec Toloza et al 57% / 82% 84% / 89%(Chest 2003) Gould et al 61% / 79% 85% / 90%(Ann Intern Med 2003)
The size of mediastinal lymph nodesand its relation with metastatict tiinvolvement; a meta-analysisanalysisde Langen, Eur J Cardiothorac Surg 2006Cases with enlarged node on CT, but –ve PET10-1515 mm ; Post test prob. for N2 = 5%16-20mm ; Post test prob. for N2 = 21%
Page 1 and 2: Role of PET-CT inPulmonary Malignan
Page 3 and 4: CLINICAL APPLICATION OFPET SCAN ONC
Page 5 and 6: F-18-FDG PET - IndicationsPrimary T
Page 7: TRACER FOR PET C-11 acetate N-13amm
Page 10 and 11: CLINICAL ASPECT OF PET Primary stag
Page 12 and 13: PET/FDG in Lung Cancer Prognosis Ra
Page 15 and 16: Diagnosis i SPNMeta-analysisanalysi
Page 20 and 21: Diagnosis i SPNROLE of FDG/PETInter
Page 22 and 23: Study in Khon Khan U Benign 50 % Pr
Page 24 and 25: AJR 2006; 187:13611361-13671367Sens
Page 26 and 27: CT 93%/ %/3131% ( sen/spec)PET 69%/
Page 28 and 29: Is there a role for PET in theevalu
Page 37: Staging:NSCLCT staging (CT is more
Page 42 and 43: CT scan The NCCN guideline panel :
Page 46 and 47: Mediastinoscopy is the gold standar
Page 56 and 57: Advances in PET technologyhave incr
Page 63 and 64: Can PET/CT substitute for bonescint
Page 65 and 66: 145 patients on a lesion-byby-lesio
Page 67: skeletal l metastases t were detect
Page 74: 1 year later
Page 82 and 83: Adrenal gl met Adrenal metastases a
Page 84 and 85: 51 of 175 masses were 1.5 cm orless
Page 86 and 87: Eur J Nucl Med Imaging 2006Jan;33(1
Page 89 and 90: StagingNSCLCImpact of PET/FDG stagi
Page 91 and 92: Thank you
Page 93 and 94: lymphangitis carcinomatosis Less of

Role of PET Role of PET-CT in Pulmonary Malignancy

Create successful ePaper yourself

Delete template?

Save as template?